Takeda Pharmaceutical (TAK) Land & Improvements (2017 - 2019)

Takeda Pharmaceutical's Land & Improvements history runs 3 years deep, the most recent figure standing at $312.1 million for Q1 2019.

• In Q1 2019, Land & Improvements changed N/A year-over-year to $312.1 million; the TTM figure through Mar 2019 stood at $312.1 million (changed N/A YoY), while the FY2019 annual figure was $312.1 million, changed N/A from the prior year.
• Land & Improvements for Q1 2019 stood at $312.1 million, up from $295.6 million in the prior quarter.
• The five-year high for Land & Improvements was $332.3 million in Q4 2017, with the low at $295.6 million in Q4 2018.
• The 3-year median for Land & Improvements is $312.1 million (2019), against an average of $313.3 million.
• Peak annual rise in Land & Improvements reached 11.04% in 2018, while the deepest fall reached 11.04% in 2018.
• Takeda Pharmaceutical's Land & Improvements stood at $332.3 million in 2017, then declined by 11.04% to $295.6 million in 2018, then rose by 5.6% to $312.1 million in 2019.
• Business Quant data shows TAK's Land & Improvements at $312.1 million in Q1 2019, $295.6 million in Q4 2018, and $332.3 million in Q4 2017.